A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.
Idris A, Davis A, Supramaniam A, Acharya D, Kelly G, Tayyar Y, West N, Zhang P, McMillan CLD, Soemardy C, Ray R, O'Meally D, Scott TA, McMillan NAJ, Morris KV.
Idris A, et al. Among authors: mcmillan cld, mcmillan naj.
Mol Ther. 2021 Jul 7;29(7):2219-2226. doi: 10.1016/j.ymthe.2021.05.004. Epub 2021 May 14.
Mol Ther. 2021.
PMID: 33992805
Free PMC article.